“Pharma made in Europe” – but only with intelligent automation
Across Europe, shortages of essential medicines such as antibiotics, fever remedies, and painkillers occur repeatedly. The reason: these products are often manufactured more cost-effectively in Asia. As a result, geopolitical disruptions and supply chain interruptions can quickly lead to shortages. The European Union has recently responded by agreeing on new rules aimed at strengthening the domestic production of critical medicines and active pharmaceutical ingredients. However, one key question remains: how can “Pharma made in Europe” be produced at scale, with the same quality and comparable unit costs? Cost and efficiency pressures persist. What is needed is a new production logic—moving away from rigid lines toward adaptive architectures.
Across Europe, shortages of essential medicines such as antibiotics, fever remedies, and painkillers occur repeatedly. The reason: these products are often manufactured more cost-effectively in Asia. As a result, geopolitical disruptions and supply…